Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Director comp.
CC transcript
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPDI) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/06/2011 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/05/2011 8-K Quarterly results
12/05/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
11/15/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/14/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/10/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/07/2011 8-K Form 8-K - Current report
11/02/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
11/02/2011 10-Q Quarterly Report for the period ended September 30, 2011
10/28/2011 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
10/17/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/14/2011 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition
10/03/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
10/03/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Pharmaceutical Product Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc",
"PPD to be Acquired by The Carlyle Group and Hellman & Friedman"
10/03/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
09/22/2011 8-K Appointed a new director
Docs: "PPD Appoints Raymond Hill as Chief Executive Officer and Member of the Board of Directors"
08/16/2011 BW PPD Names Jasmine (Jisong) Cui Chief Scientific Officer of BioDuro
08/04/2011 10-Q Quarterly Report for the period ended June 30, 2011
07/27/2011 TRN Pharmaceutical Product Development CEO Discusses Q2 2011 Results
07/26/2011 8-K Quarterly results
Docs: "PPD Reports Second Quarter 2011 Financial Results"
07/18/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "PPD Comments on Recent Stock Market Developments"
06/27/2011 BW PPD Names Edward Ian Vice President of Clinical Development for Asia Pacific
05/31/2011 BW PPD Awarded U.S. Army Contract to Support Biodefense and Vaccine Development Programs
05/19/2011 BW PPD Declares Second Quarter Dividend
05/19/2011 8-K Form 8-K - Current report
05/09/2011 BW PPD Expands Product Development Consulting Services Across Four Practice Areas
05/06/2011 BW PPD's Mike Wilkinson Appointed by Gov. Perdue to U.S.S. North Carolina Battleship Commission
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy